Kyle Guse
2021
In 2021, Kyle Guse earned a total compensation of $2.8M as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $205,515 |
|---|---|
| Option Awards | $2,108,013 |
| Salary | $456,700 |
| Other | $31,400 |
| Total | $2,801,628 |
Guse received $2.1M in option awards, accounting for 75% of the total pay in 2021.
Guse also received $205.5K in non-equity incentive plan, $456.7K in salary and $31.4K in other compensation.
Rankings
In 2021, Kyle Guse's compensation ranked 4,697th out of 12,405 executives tracked by ExecPay. In other words, Guse earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,697 out of 12,405 | 62nd |
Division Manufacturing | 1,949 out of 5,494 | 65th |
Major group Chemicals And Allied Products | 814 out of 2,369 | 66th |
Industry group Drugs | 727 out of 2,090 | 65th |
Industry Pharmaceutical Preparations | 518 out of 1,537 | 66th |
Source: SEC filing on April 11, 2022.
Guse's colleagues
We found one more compensation record of an executive who worked with Kyle Guse at Atossa Genetics in 2021.
2021
Steven Quay
Atossa Genetics
Chief Executive Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019